Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe.

Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.

This file photo shows Sun Yuanxia looking at sugar in a lab at the Tianjin Institute of Industrial Biotechnology in north ...

Now he’s at the forefront of a large, impactful discussion: the pros and cons of artificial intelligence in the field of synthetic biology. Vitalis performing lab work in the Genetic Logic Lab under ...